{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:12:31Z","timestamp":1789909951498,"version":"4.0.1"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"EU FP7 InCOMB"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1002\/nau.22558","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T14:59:29Z","timestamp":1389884369000},"page":"602-605","source":"Crossref","is-referenced-by-count":29,"title":["What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013"],"prefix":"10.1002","volume":"33","author":[{"given":"Christopher H.","family":"Fry","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Physiology; University of Surrey; Guildford Surrey United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[{"name":"Department of Urology; Guy's and St Thomas' NHS Trust; London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Vahabi","sequence":"additional","affiliation":[{"name":"Bristol Urological Institute; Southmead Hospital NHS Trust; Bristol Avon United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Pittsburgh; Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Birder","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Pittsburgh; Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"10.1002\/nau.22558-BIB0001|nau22558-cit-0001","doi-asserted-by":"crossref","first-page":"37836","DOI":"10.1074\/jbc.M604581200","article-title":"CKAP4\/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients","volume":"281","author":"Conrads","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/nau.22558-BIB0002|nau22558-cit-0002","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.1073\/pnas.0404509101","article-title":"An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide","volume":"101","author":"Keay","year":"2004","journal-title":"PNAS"},{"key":"10.1002\/nau.22558-BIB0003|nau22558-cit-0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0090-4295(01)01127-X","article-title":"Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis","volume":"57","author":"Keay","year":"2001","journal-title":"Urology"},{"key":"10.1002\/nau.22558-BIB0004|nau22558-cit-0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0090-4295(01)01028-7","article-title":"Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: Sensitive and specific urine markers for interstitial cystitis","volume":"57","author":"Keay","year":"2001","journal-title":"Urology"},{"key":"10.1002\/nau.22558-BIB0005|nau22558-cit-0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2490-5-7","article-title":"APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis","volume":"29","author":"Zhang","year":"2005","journal-title":"BMC Urol"},{"key":"10.1002\/nau.22558-BIB0006|nau22558-cit-0006","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.juro.2008.01.047","article-title":"Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis\/painful bladder syndrome","volume":"179","author":"Erickson","year":"2008","journal-title":"J Urol"},{"key":"10.1002\/nau.22558-BIB0007|nau22558-cit-0007","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","article-title":"Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/painful bladder syndrome","volume":"108","author":"Shie","year":"2011","journal-title":"BJU Int"},{"key":"10.1002\/nau.22558-BIB0008|nau22558-cit-0008","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0022-5347(05)68800-3","article-title":"The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis","volume":"161","author":"Byrne","year":"1999","journal-title":"J Urol"},{"key":"10.1002\/nau.22558-BIB0009|nau22558-cit-0009","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","volume":"27","author":"Roy","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/nau.22558-BIB0010|nau22558-cit-0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/postgradmedj-2011-300775rep","article-title":"Bacterial proteases in IBD and IBS","volume":"89","author":"Steck","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1002\/nau.22558-BIB0011|nau22558-cit-0011","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2013.04.003","article-title":"Painful Na-channelopathies: An expanding universe","volume":"19","author":"Waxman","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1002\/nau.22558-BIB0012|nau22558-cit-0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/00365599.2012.699100","article-title":"Bladder pain syndrome\/interstitial cystitis ESSIC type 3C: High expression of inducible nitric oxide synthase in inflammatory cells","volume":"47","author":"Logadottir","year":"2013","journal-title":"Scand J Urol"},{"key":"10.1002\/nau.22558-BIB0013|nau22558-cit-0013","first-page":"36","article-title":"Future assessments of overactive bladder","volume":"7","author":"Cruz","year":"2012","journal-title":"Eur Urol Rev"},{"key":"10.1002\/nau.22558-BIB0014|nau22558-cit-0014","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00192-012-2027-1","article-title":"Biomarkers in overactive bladder","volume":"24","author":"Bhide","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22558-BIB0015|nau22558-cit-0015","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0022-5347(05)64369-8","article-title":"Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats","volume":"168","author":"Seki","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/nau.22558-BIB0016|nau22558-cit-0016","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","article-title":"Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection","volume":"56","author":"Liu","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22558-BIB0017|nau22558-cit-0017","first-page":"e69","article-title":"Can urinary nerve growth factor be a biomarker for overactive bladder","volume":"12","author":"Kuo","year":"2010","journal-title":"Rev Urol"},{"key":"10.1002\/nau.22558-BIB0018|nau22558-cit-0018","first-page":"382431","article-title":"Biomarkers in overactive bladder: A new objective and noninvasive tool","volume":"2011","author":"Lopes","year":"2011","journal-title":"Adv Urol"},{"key":"10.1002\/nau.22558-BIB0019|nau22558-cit-0019","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","article-title":"Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity","volume":"106","author":"Liu","year":"2010","journal-title":"BJU Int"},{"key":"10.1002\/nau.22558-BIB0020|nau22558-cit-0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0929-6646(10)60133-7","article-title":"Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders","volume":"109","author":"Liu","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"10.1002\/nau.22558-BIB0021|nau22558-cit-0021","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1464-410X.2009.08380.x","article-title":"Decrease of urinary nerve growth factor levels after antimuscaric therapy in patients with overactive bladder","volume":"103","author":"Liu","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22558-BIB0022|nau22558-cit-0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.juro.2012.08.187","article-title":"Urinary neurotrophic factors in health individuals and patients with overactive bladder","volume":"189","author":"Antunes-Lopes","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/nau.22558-BIB0023|nau22558-cit-0023","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","article-title":"Trigonal injection of botulinum toxin A in patients with refractory bladder pain\/interstitial cystitis","volume":"58","author":"Pinto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22558-BIB0024|nau22558-cit-0024","doi-asserted-by":"crossref","first-page":"1267.e13","DOI":"10.1016\/j.urology.2010.06.012","article-title":"Urinary prostaglandin E2 was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome","volume":"76","author":"Yamauchi","year":"2010","journal-title":"Urology"},{"key":"10.1002\/nau.22558-BIB0025|nau22558-cit-0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","article-title":"Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom","volume":"12","author":"Kim","year":"2005","journal-title":"Int J Urol"},{"key":"10.1002\/nau.22558-BIB0026|nau22558-cit-0026","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","article-title":"Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity","volume":"106","author":"Liu","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22558-BIB0027|nau22558-cit-0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","article-title":"Urine cytokines suggest an inflammatory response in the overactive bladder: A pilot study","volume":"42","author":"Tyagi","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/nau.22558-BIB0028|nau22558-cit-0028","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00192-011-1401-8","article-title":"Differential profile analysis of urinary cytokines in patients with overactive bladder","volume":"22","author":"Ghoniem","year":"2011","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22558-BIB0029|nau22558-cit-0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/nau.20938","article-title":"Elevation of serum C-reactive protein in patients with OAB and IC\/BPS implies chronic inflammation in the urinary bladder","volume":"30","author":"Chung","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22558-BIB0030|nau22558-cit-0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00192-012-1715-1","article-title":"The role of serum C-reactive protein in women with lower urinary tract symptoms","volume":"23","author":"Hsaio","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22558-BIB0031|nau22558-cit-0031","doi-asserted-by":"crossref","first-page":"e64696","DOI":"10.1371\/journal.pone.0064696","article-title":"Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome","volume":"8","author":"Silva-Ramos","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/nau.22558-BIB0032|nau22558-cit-0032","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0022-5347(05)65726-6","article-title":"Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis","volume":"166","author":"Sun","year":"2001","journal-title":"J Urol"},{"key":"10.1002\/nau.22558-BIB0033|nau22558-cit-0033","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejphar.2012.02.041","article-title":"Acid and stretch, but not capsaicin, are effective stimuli for ATP release in the porcine bladder mucosa: Are ASIC and TRPV1 receptors involved","volume":"683","author":"Sadananda","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/nau.22558-BIB0034|nau22558-cit-0034","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/nau.22344","article-title":"Correlation between cystometric volumes, ATP release and pH in women with overactive bladder versus controls","volume":"32","author":"Cheng","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22558-BIB0035|nau22558-cit-0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2220\/biomedres.30.107","article-title":"Comparison of the effect of anti-muscarinic agents on bladder activity, urinary ATP level, and autonomic nervous system in rats","volume":"30","author":"Nishijima","year":"2009","journal-title":"Biomed Res"},{"key":"10.1002\/nau.22558-BIB0036|nau22558-cit-0036","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2220\/biomedres.30.287","article-title":"Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder","volume":"30","author":"Sugaya","year":"2009","journal-title":"Biomed Res"},{"key":"10.1002\/nau.22558-BIB0037|nau22558-cit-0037","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"10.1002\/nau.22558-BIB0038|nau22558-cit-0038","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/nau.20908","article-title":"Genetics and the lower urinary tract","volume":"29","author":"Norton","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22558-BIB0039|nau22558-cit-0039","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/bmj.329.7471.889","article-title":"Familial risk of urinary incontinence in women: Population based cross sectional study","volume":"329","author":"Hannestad","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/nau.22558-BIB0040|nau22558-cit-0040","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.0001-6349.2004.00635.x","article-title":"Genetic and environmental influences on urinary incontinence: A Danish population-based twin study of middle-aged and elderly women","volume":"83","author":"Rohr","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1002\/nau.22558-BIB0041|nau22558-cit-0041","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.eururo.2011.03.007","article-title":"Genetic influences are important for most but not all lower urinary tract symptoms: A population-based survey in a cohort of adult Swedish twins","volume":"59","author":"Wennberg","year":"2011","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22558-BIB0042|nau22558-cit-0042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2011.7","article-title":"Novel biomarkers for overactive bladder","volume":"8","author":"Cartwright","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1002\/nau.22558-BIB0043|nau22558-cit-0043","doi-asserted-by":"crossref","first-page":"82.e10","DOI":"10.1016\/j.ajog.2011.02.052","article-title":"The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder","volume":"205","author":"Ferreira","year":"2011","journal-title":"Am J Obstet Gynaecol"},{"key":"10.1002\/nau.22558-BIB0044|nau22558-cit-0044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2008.00014.x","article-title":"Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors","volume":"156","author":"Vrydag","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1002\/nau.22558-BIB0045|nau22558-cit-0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.beem.2011.09.002","article-title":"Is genetic testing useful to predict type 2 diabetes","volume":"26","author":"Vassy","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1002\/nau.22558-BIB0046|nau22558-cit-0046","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.urology.2009.06.021","article-title":"Peripheral blood mononuclear cell gene array profiles in patients with overactive bladder","volume":"75","author":"Cheung","year":"2010","journal-title":"Urology"},{"key":"10.1002\/nau.22558-BIB0047|nau22558-cit-0047","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fgene.2012.00310","article-title":"Characteristic patterns of microRNA expression in human bladder cancer","volume":"3","author":"Zabolotneva","year":"2013","journal-title":"Front Genet"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22558","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22558","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22558\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T21:51:43Z","timestamp":1625349103000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22558"}},"subtitle":["Biomarkers and Lower Urinary Tract Disorders"],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22558","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}